CCA
TMO icon

Catalyst Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Catalyst Capital Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-20
Closed -$35K – 627
2015
Q4 		$35K Hold
20
– – 0.01% 379
2015
Q3 		$10K Hold
20
– – ﹤0.01% 479
2015
Q2 		$22K Buy
+20
New +$2.61K ﹤0.01% 387

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Catalyst Capital Advisors's TMO Position: Q2 2024 in Review

Catalyst Capital Advisors sold out of Thermo Fisher Scientific (TMO) in Q2 2024, closing a stake of 50 shares — an estimated $29.1K sold.

Catalyst Capital Advisors first reported a position in TMO in Q1 2016 and held it in 17 quarters. The position peaked at $2.46M in Q2 2016. 2,542 funds tracked by Wall St. Rank hold TMO as of Q2 2024.

  • Catalyst Capital Advisors reported no remaining Thermo Fisher Scientific position as of Q2 2024 after selling out during the quarter.
  • Catalyst Capital Advisors sold 50 Thermo Fisher Scientific shares in Q2 2024, an estimated $29.1K.
  • Catalyst Capital Advisors first reported a position in Thermo Fisher Scientific in Q1 2016 and held it in 17 quarters.
  • Catalyst Capital Advisors's Thermo Fisher Scientific position peaked at $2.46M in Q2 2016.
  • 2,542 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.

Based on Catalyst Capital Advisors's 13F filing for Q2 2024, filed 25 Jul 2024.